According to a study recently published in Blood Advances, quality of life (QoL) suffers and physical and mental symptoms worsen in adults with hematologic malignancies receiving...
According to a recent study that was published in Blood Advances, adults with hematologic malignancies receiving chimeric antigen receptor T-cell (CAR-T) therapy experience a decline in...
